Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy

Qiong Ye, Carsten Friedrich Danzer, Alexander Fuchs, Christian Wolfrum, Markus Rudin, Qiong Ye, Carsten Friedrich Danzer, Alexander Fuchs, Christian Wolfrum, Markus Rudin

Abstract

Object: Hepatic lipid accumulation is associated with nonalcoholic fatty liver disease, and the metabolic syndrome constitutes an increasing medical problem. In vivo proton magnetic resonance spectroscopy ((1)H MRS) allows the assessment of hepatic lipid levels noninvasively and also yields information on the fat composition due to its high spectral resolution.

Materials and methods: We applied (1)H MRS at 9.4T to study lipid content and composition in eight leptin-deficient ob/ob mice as a model of obesity and in four lean ob/+ control mice at 24 weeks of age. PRESS sequence was used. For accurate estimation of signal intensity, differences in relaxation behavior of individual signals were accounted for each mouse individually. Also, in order to minimize spectral degrading due to motion artifacts, respiration gating was applied.

Results: Significant differences between ob/ob and ob/+ control mice were found in both lipid content and composition. The mean chain length was found to be significantly longer in ob/ob mice with a higher fraction of monounsaturated lipids.

Conclusion: (1)H MRS enables accurate assessment in hepatic lipids in mice, which is attractive for mechanistic studies of altered metabolism given the large number of genetically engineered mouse models available.

References

    1. J Lipid Res. 2011 Feb;52(2):330-6
    1. J Lipid Res. 1997 Jul;38(7):1277-88
    1. J Lipid Res. 1999 Aug;40(8):1395-400
    1. J Magn Reson Imaging. 2011 Dec;34(6):1388-96
    1. Obesity (Silver Spring). 2006 Mar;14(3):405-14
    1. NMR Biomed. 2011 Dec;24(10):1295-301
    1. Magn Reson Med. 2012 Jan;67(1):20-6
    1. Chem Phys Lipids. 2008 Feb;151(2):103-9
    1. Pharmacology. 2009;84(3):183-90
    1. Metabolism. 1983 Feb;32(2):172-8
    1. Diabetologia. 2006 Apr;49(4):784-91
    1. NMR Biomed. 2011 Jul;24(6):592-611
    1. Biochim Biophys Acta. 2009 Aug;1791(8):757-63
    1. Magn Reson Med. 2006 Apr;55(4):913-7
    1. J Lipid Res. 2008 Feb;49(2):473-80
    1. J Magn Reson Imaging. 2010 Jun;31(6):1514-21
    1. Magn Reson Med. 2006 Aug;56(2):386-94
    1. NMR Biomed. 2011 Apr;24(3):238-45
    1. Hepatology. 2008 May;47(5):1513-23
    1. Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):625-35
    1. J Lipid Res. 1994 Dec;35(12):2191-9
    1. Magn Reson Med. 2000 Aug;44(2):201-7
    1. Comp Biochem Physiol B Biochem Mol Biol. 1994 Oct-Nov;109(2-3):273-80
    1. Lipids. 2011 Jul;46(7):659-67
    1. J Lipid Res. 2008 Jul;49(7):1375-6
    1. Ann Med. 2005;37(5):347-56
    1. Int J Exp Pathol. 2006 Feb;87(1):1-16
    1. Nat Med. 2007 Oct;13(10):1193-202
    1. NMR Biomed. 2003 May;16(3):160-7
    1. Pharm Res. 2006 Jun;23(6):1075-88
    1. J Lipid Res. 2006 Feb;47(2):310-7
    1. J Lipid Res. 2008 Sep;49(9):2055-62
    1. Magn Reson Med. 2001 Nov;46(5):879-83
    1. AJNR Am J Neuroradiol. 2009 Jun;30(6):1096-101
    1. J Lipid Res. 2009 Apr;50(4):611-22
    1. Rev Endocr Metab Disord. 2004 May;5(2):127-34
    1. J Lipid Res. 2004 Jul;45(7):1364-71
    1. ScientificWorldJournal. 2007 May 29;7:666-85
    1. Obesity (Silver Spring). 2007 Jan;15(1):69-77

Source: PubMed

3
订阅